Company intelligence / Profile preview

Altruist Biologics

Ownership: Private
Employees: ~1150
Development stage: Commercial

Overview

Altruist Biologics is an active global CDMO with large-scale GMP-compliant facilities in Suzhou and Hangzhou, China. The company has supported 30+ INDs in China, 10+ INDs in the US, 3 INDs in Australia, 8 NDAs in China, and 1 BLA filing in the US. It currently manufactures four commercial antibody products with over 700 successful batches completed. Facilities meet FDA/EMA/NMPA standards.

Modalities: Monoclonal antibodiesFusion proteinsAntibody-drug conjugates (ADCs)Cell therapiesGene therapies
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Altruist Biologics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Altruist Biologics.

Explore the full profile